Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension
- 1 January 1983
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 105 (1), 106-112
- https://doi.org/10.1016/0002-8703(83)90286-7
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failureAmerican Heart Journal, 1981
- HAEMODYNAMIC, HORMONAL, AND ELECTROLYTE RESPONSES TO CAPTOPRIL IN RESISTANT HEART FAILUREThe Lancet, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Constrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopril).Circulation, 1980
- Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension: Predictability of plasma renin status from hemodynamic changesThe American Journal of Cardiology, 1978
- Hemodynamic correlates of saralasin-induced arterial pressure changes.Circulation, 1978
- Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasinThe American Journal of Medicine, 1976
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973